Tag: Covid Vaccine

Naveen-Patnaik
Odisha Govt Announces Free Covid-19 Vaccination For All Above 18 Years

Bhubaneswar: Odisha Chief Minister Naveen Patnaik on Sunday announced free vaccination for all people above 18 years of age. Addressing the people of the State through video conferencing, Patnaik informed…

  • Sunday, 25 April 2021
Remdesivir Production Will Be Up From 38.80 Lakh Units/Month To 74 Lakh Units/Month By May: MHA
Remdesivir Production Will Be Up From 38.80 Lakh Units/Month To 74 Lakh Units/Month By May: MHA

New Delhi: The Union home ministry said several steps have been taken to augment the production and supply of Remdesivir injections from 38.80 lakh units per month to 74 lakh…

  • Friday, 23 April 2021
Oxford-AstraZeneca's 'Covishield' Gets Expert Panel's Clearance, Awaits DCGI Nod
Covishield Priced At Rs 600/Dose For Pvt Hospitals, Rs 400/Dose For State Govts

New Delhi: Serum Institute of India (SII), the world’s largest vaccine maker, on Wednesday announced a price of Rs 600 per dose for COVID vaccine supplies to private hospitals and…

  • Wednesday, 21 April 2021
naveen-modi
Make Available Covid-19 Vaccine In Open Market, Flexibility In Age Criteria: Odisha CM To PM Modi

Bhubaneswar: Underlining the importance of Centre and States working together as a team to face Covid crisis, Odisha Chief Minister Naveen Patnaik has urged Prime Minister Narendra Modi to scale…

  • Saturday, 17 April 2021
Intelligent-Testing-Strateg
Intelligent Testing Strategy For Being 'Ahead Of Virus': ICMR

New Delhi: The Indian Council of Medical Research on Monday said that India developed an Intelligent Testing Strategy to remain ‘ahead of the virus’ by developing testing infrastructure that is laboratories and other means of testing. According to ICMR, the country now has a capacity of testing 2 lakh samples per day. “India now has […]

  • Friday, 16 April 2021
GSk--GlaxoSmithKline
GSK To Produce One Billion Doses Of Covid-19 Vaccine Booster Next Year

London: Pharmaceutical giant GlaxoSmithKline on Thursday said it plans to produce 1 billion doses of coronavirus vaccine adjuvant, an ingredient that makes vaccines work better, in 2021 to support multiple Covid-19 vaccine collaborations. Saying that it has started manufacture of the adjuvant at risk, the company added that it was in discussions with governments and […]

  • Friday, 16 April 2021
COVID-19-vaccine
Johnson & Johnson To Begin Human Trial Of Covid Vaccine In July

New York: Johnson & Johnson on Wednesday said that it has accelerated the first in-human clinical trial of its investigational SARS-CoV-2 vaccine in the second half of July via its Janssen Pharmaceutical Companies (Janssen). The trial for the vaccine, Ad26.COV2-S, recombinant, was initially scheduled to begin in September. “Based on the strength of the preclinical […]

  • Friday, 16 April 2021
Covaxin
COVID Vaccine: Bharat Biotech Begins Human Trial Of Covaxin In India

Chandigarh: The human trial of Bharat Biotech’s anti-COVID-19 vaccine Covaxin began at Rohtak’s Post-Graduate Institute of Medical Sciences on Friday, Haryana Health Minister Anil Vij tweeted. In his tweet, the minister also said the vaccine has been administered to three persons who have shown no adverse effect to it. “Human trial with Corona vaccine (COVAXIN) […]

  • Thursday, 15 April 2021
Covaxin's Phase-3 Trials Begin: Bharat Biotech
AIIMS To Begin COVID Vaccine Human Trial From Next Week

New Delhi: In a major development, AIIMS Delhi will begin human trials of India’s first indigenous Covid-19 vaccine, Covaxin, from next week on 100 healthy volunteers aged between 18 and 55. The volunteers will be kept under observation for a period of nearly 150 days. Covaxin is developed by Bharat Biotech in collaboration with the […]

  • Wednesday, 14 April 2021
COVID19 Vaccine in India
Seven Indian Pharma Players Race To Develop COVID-19 Vaccine

New Delhi: At least seven Indian pharma companies are working to develop a vaccine against coronavirus as they join global efforts to find a preventive to check the spread of the deadly virus that has already infected more than 14 million globally. Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological […]

  • Wednesday, 14 April 2021
Covaxin-clinical Trail
Clinical Trials Of COVID Vaccine Set To Start In Bhubaneswar From Wednesday

Bhubaneswar: Human clinical trials of the country’s indigenously developed COVID-19 vaccine is set to begin this week at a Bhubaneswar-based institute — one of the 12 centres selected by the ICMR for conducting phase one and two of the process, a senior official said. The human trials of BBV152 COVID Vaccine or Covaxin will begin […]

  • Wednesday, 14 April 2021
Odisha-CM
Covid Vaccine In India Likely By 2020 End! Odisha CM Holds Talks With Serum Institute CEO

Bhubaneswar: Odisha Chief Minister Naveen Patnaik talked to Adar Poonawalla, CEO of Serum Institute over a video call today to discuss on progress of Covid vaccine. The Chief Minister expressed happiness that Serum Institute has partnered with Oxford University to develop Covid vaccine and sought his cooperation to begin early vaccination in Odisha once necessary […]

  • Wednesday, 14 April 2021
COVID19: Pharma Firms Ramping Production Of Remdesivir To Meet Demand
COVID19: Pharma Firms Ramping Production Of Remdesivir To Meet Demand

New Delhi: Several manufacturers of Remdesivir, that is being used in treatment of COVID-19, said they have ramped up production of the drug to meet its rising demand across the…

  • Wednesday, 14 April 2021
COVID-19-Vaccine
Covid Vaccine: Pfizer, BioNTech Begin Late Stage Clinical Trials

New York: US-based Pfizer and German biotech firm BioNTech have announced the start of a late stage clinical trial of a Covid-19 vaccine jointly developed by the two companies. The Phase 2/3 study will involve up to 30,000 participants between 18 and 85 years of age, the two companies said on Monday. The vaccine candidate, […]

  • Wednesday, 14 April 2021
Moderna-COVID-Vaccine
Fighting Coronavirus: Moderna's Covid Vaccine Successful In Monkeys

New York: Pharmaceutical company Moderna’s Covid-19 vaccine, which is currently in clinical trials, has shown successful results in monkeys. Two doses of an experimental vaccine known as mRNA-1273 induced robust immune responses and rapidly controlled the Covid-19 in the upper and lower airways of Monkeys exposed to SARS-CoV-2, the National Institute of Allergy and Infectious […]

  • Wednesday, 14 April 2021
scrollToTop